Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 19

1.

Long-term outcome of liver transplants for chronic hepatitis C: a 10-year follow-up.

Neumann UP, Berg T, Bahra M, Puhl G, Guckelberger O, Langrehr JM, Neuhaus P.

Transplantation. 2004 Jan 27;77(2):226-31.

PMID:
14742986
2.

No tolerance for depletion.

Auchincloss H.

Nat Med. 2004 Jan;10(1):21-3. No abstract available.

PMID:
14702625
3.

Homeostatic proliferation is a barrier to transplantation tolerance.

Wu Z, Bensinger SJ, Zhang J, Chen C, Yuan X, Huang X, Markmann JF, Kassaee A, Rosengard BR, Hancock WW, Sayegh MH, Turka LA.

Nat Med. 2004 Jan;10(1):87-92. Epub 2003 Nov 30.

4.

Kidney transplantation under a tolerogenic regimen of recipient pretreatment and low-dose postoperative immunosuppression with subsequent weaning.

Shapiro R, Jordan ML, Basu A, Scantlebury V, Potdar S, Tan HP, Gray EA, Randhawa PS, Murase N, Zeevi A, Demetris AJ, Woodward J, Marcos A, Fung JJ, Starzl TE.

Ann Surg. 2003 Oct;238(4):520-5; discussion 525-7.

5.
6.

Results from a human renal allograft tolerance trial evaluating the humanized CD52-specific monoclonal antibody alemtuzumab (CAMPATH-1H).

Kirk AD, Hale DA, Mannon RB, Kleiner DE, Hoffmann SC, Kampen RL, Cendales LK, Tadaki DK, Harlan DM, Swanson SJ.

Transplantation. 2003 Jul 15;76(1):120-9.

PMID:
12865797
7.

Campath-1H induction plus rapamycin monotherapy for renal transplantation: results of a pilot study.

Knechtle SJ, Pirsch JD, H Fechner J Jr, Becker BN, Friedl A, Colvin RB, Lebeck LK, Chin LT, Becker YT, Odorico JS, D'Alessandro AM, Kalayoglu M, Hamawy MM, Hu H, Bloom DD, Sollinger HW.

Am J Transplant. 2003 Jun;3(6):722-30.

8.

Tolerogenic immunosuppression for organ transplantation.

Starzl TE, Murase N, Abu-Elmagd K, Gray EA, Shapiro R, Eghtesad B, Corry RJ, Jordan ML, Fontes P, Gayowski T, Bond G, Scantlebury VP, Potdar S, Randhawa P, Wu T, Zeevi A, Nalesnik MA, Woodward J, Marcos A, Trucco M, Demetris AJ, Fung JJ.

Lancet. 2003 May 3;361(9368):1502-10.

9.

Preliminary experience with campath 1H (C1H) in intestinal and liver transplantation.

Tzakis AG, Kato T, Nishida S, Levi DM, Madariaga JR, Nery JR, Mittal N, Regev A, Cantwell P, Gyamfi A, Weppler D, Miller J, Tryphonopoulos P, Ruiz P.

Transplantation. 2003 Apr 27;75(8):1227-31.

PMID:
12717207
10.

Real-time monitoring of acute liver-allograft rejection using the Banff schema.

Demetris AJ, Ruppert K, Dvorchik I, Jain A, Minervini M, Nalesnik MA, Randhawa P, Wu T, Zeevi A, Abu-Elmagd K, Eghtesad B, Fontes P, Cacciarelli T, Marsh W, Geller D, Fung JJ.

Transplantation. 2002 Nov 15;74(9):1290-6.

PMID:
12451268
11.

Impact of immunosuppressive therapy on recurrence of hepatitis C.

Everson GT.

Liver Transpl. 2002 Oct;8(10 Suppl 1):S19-27. Review.

12.

Transplantation tolerance from a historical perspective.

Starzl TE, Zinkernagel RM.

Nat Rev Immunol. 2001 Dec;1(3):233-9. doi: 10.1038/35105088. Review.

13.

A 10-year experience of liver transplantation for hepatitis C: analysis of factors determining outcome in over 500 patients.

Ghobrial RM, Steadman R, Gornbein J, Lassman C, Holt CD, Chen P, Farmer DG, Yersiz H, Danino N, Collisson E, Baquarizo A, Han SS, Saab S, Goldstein LI, Donovan JA, Esrason K, Busuttil RW.

Ann Surg. 2001 Sep;234(3):384-93; discussion 393-4.

14.

Antigen localization and migration in immunity and tolerance.

Starzl TE, Zinkernagel RM.

N Engl J Med. 1998 Dec 24;339(26):1905-13. Review. No abstract available.

15.

Prope tolerance, perioperative campath 1H, and low-dose cyclosporin monotherapy in renal allograft recipients.

Calne R, Friend P, Moffatt S, Bradley A, Hale G, Firth J, Bradley J, Smith K, Waldmann H.

Lancet. 1998 Jun 6;351(9117):1701-2. No abstract available. Erratum in: Lancet 1998 Aug 1;352(9125):408.

PMID:
9734890
16.

Banff schema for grading liver allograft rejection: an international consensus document.

[No authors listed]

Hepatology. 1997 Mar;25(3):658-63. Review.

PMID:
9049215
17.

Studies on heterologous anti-lymphocyte serum in mice. II. Effect on the immune response.

Monaco AP, Wood ML, Gray JG, Russell PS.

J Immunol. 1966 Feb;96(2):229-38. No abstract available.

PMID:
5327056
18.

The use of heterologous antilymphoid agents in canine renal and liver homotransplantation and in human renal homotransplantation.

Starzl TE, Marchioro TL, Porter KA, Iwasaki Y, Cerilli GJ.

Surg Gynecol Obstet. 1967 Feb;124(2):301-8. No abstract available.

19.

Specificity of monoclonal antibody Campath-1.

Hale G, Waldmann H, Dyer M.

Bone Marrow Transplant. 1988 May;3(3):237-9. No abstract available.

PMID:
3048490

Supplemental Content

Support Center